Natalie McCan, Senior Director of Business Development, brings 25 years of experience from the life sciences and pharma industries to her role at Quotient Sciences. Based on the West Coast, USA, Natalie is part of our Translational Pharmaceutics business development team.

Throughout her career, Natalie has maintained a strong focus on establishing new business accounts, managing strategic relationships with key accounts, and driving long-term revenue growth with large pharma as well as small to medium-sized biotechs. She has a diverse background across the entire drug development process, including preclinical and clinical phases through commercialization, manufacturing, supply chain management, home health, diagnostics, and market access within healthcare systems.

Natalie's experience includes prior roles with CRO and CDMO companies including Emmes, Caliper Life Sciences, Pharmaron, and Cambrex, as well as with Quotient Sciences nine years ago in a business development role focused on Synthesis-to-Clinic integrated ADME programs.

Natalie holds a degree in Kinesiology from San Francisco State University.